-
1
-
-
79951821210
-
Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary
-
Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-292.
-
(2011)
Clin Infect Dis
, vol.52
, pp. 285-292
-
-
Liu, C.1
Bayer, A.2
Cosgrove, S.E.3
-
2
-
-
67651083250
-
Vancomycin therapeutic guidelines: A summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
-
Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49:325-7.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 325-327
-
-
Rybak, M.J.1
Lomaestro, B.M.2
Rotschafer, J.C.3
-
3
-
-
78650648956
-
Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates
-
van Hal SJ, Paterson DL. Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates. Antimicrob Agents Chemother 2011;55:405-10.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 405-410
-
-
van Hal, S.J.1
Paterson, D.L.2
-
4
-
-
84872237844
-
Clinical and laboratory characteristics of invasive infections due to MRSA isolates demonstrating vancomycin MICs of 2 μg/mL: Lack of effect of hVISA phenotype
-
Epub 2011/02/18, doi: 10.1128/JCM.01719-10
-
Satola SW, Lessa FC, Ray SM, et al. Clinical and laboratory characteristics of invasive infections due to MRSA isolates demonstrating vancomycin MICs of 2 μg/mL: lack of effect of hVISA phenotype. J Clin Microbiol. Epub 2011/02/18. doi: 10.1128/JCM.01719-10
-
J Clin Microbiol
-
-
Satola, S.W.1
Lessa, F.C.2
Ray, S.M.3
-
5
-
-
79951948613
-
Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: A global analysis 2004-2009
-
doi: 10.1016/j.ijantimicag.2010.10.029
-
Hawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009. Int J Antimicrob Agents 2011;37:219-24. doi: 10.1016/j.ijantimicag.2010.10.029
-
(2011)
Int J Antimicrob Agents
, vol.37
, pp. 219-224
-
-
Hawser, S.P.1
Bouchillon, S.K.2
Hoban, D.J.3
Dowzicky, M.4
Babinchak, T.5
-
6
-
-
79953834313
-
Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia
-
doi: 10.1007/s00134-011-2130-7
-
Choi EY, Huh JW, Lim CM, et al. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med 2011;37:639-47. doi: 10.1007/s00134-011-2130-7
-
(2011)
Intensive Care Med
, vol.37
, pp. 639-647
-
-
Choi, E.Y.1
Huh, J.W.2
Lim, C.M.3
-
7
-
-
33748553406
-
Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis
-
doi: 10.1016/j.clinthera.2006.08.003
-
Maclayton DO, Suda KJ, Coval KA, York CB, Garey KW. Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis. Clin Ther 2006;28:1208-16.doi: 10.1016/j.clinthera.2006.08.003
-
(2006)
Clin Ther
, vol.28
, pp. 1208-1216
-
-
Maclayton, D.O.1
Suda, K.J.2
Coval, K.A.3
York, C.B.4
Garey, K.W.5
-
8
-
-
2942558870
-
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
-
doi: 10.1128/JCM.42.6.2398-2402.2004
-
Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 2004;42:2398-402.doi: 10.1128/JCM.42.6.2398-2402.2004
-
(2004)
J Clin Microbiol
, vol.42
, pp. 2398-2402
-
-
Sakoulas, G.1
Moise-Broder, P.A.2
Schentag, J.3
Forrest, A.4
Moellering Jr., R.C.5
Eliopoulos, G.M.6
-
9
-
-
33644503268
-
Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA)
-
doi: 10.1111/j.1444-0903.2005.00986.x
-
Howden BP. Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA). Intern Med J 2005;35(suppl 2):S136-40. doi: 10.1111/j.1444-0903.2005.00986.x
-
(2005)
Intern Med J
, vol.35
, Issue.1 SUPPL.
-
-
Howden, B.P.1
-
10
-
-
79953907324
-
Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: Support for consensus guidelines suggested targets
-
doi: 10.1093/cid/cir124
-
Kullar R, Davis SL, Levine DP, Rybak MJ. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis 2011;52:975-81. doi: 10.1093/cid/cir124
-
(2011)
Clin Infect Dis
, vol.52
, pp. 975-981
-
-
Kullar, R.1
Davis, S.L.2
Levine, D.P.3
Rybak, M.J.4
-
11
-
-
79960135233
-
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations
-
doi: 10.1093/infdis/jir270
-
Holmes NE, Turnidge JD, Munckhof WJ, et al. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. J Infect Dis 2011;204:340-7. doi: 10.1093/infdis/jir270
-
(2011)
J Infect Dis
, vol.204
, pp. 340-347
-
-
Holmes, N.E.1
Turnidge, J.D.2
Munckhof, W.J.3
-
12
-
-
84555204828
-
Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: A case-control study
-
doi: 10.1093/cid/cir764
-
Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 2012;54:51-8. doi: 10.1093/cid/cir764
-
(2012)
Clin Infect Dis
, vol.54
, pp. 51-58
-
-
Moore, C.L.1
Osaki-Kiyan, P.2
Haque, N.Z.3
Perri, M.B.4
Donabedian, S.5
Zervos, M.J.6
-
13
-
-
84555206655
-
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: Has the time come?
-
doi: 10.1093/cid/cir777
-
Weston A, Boucher HW. Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come? Clin Infect Dis 2012;54:59-61. doi: 10.1093/cid/cir777
-
(2012)
Clin Infect Dis
, vol.54
, pp. 59-61
-
-
Weston, A.1
Boucher, H.W.2
-
14
-
-
81855221741
-
Trimethoprimsulfamethoxazole therapy for children with acute osteomyelitis
-
doi: 10.1097/INF.0b013e31822db658
-
Messina AF, Namtu K, Guild M, Dumois JA, Berman DM. Trimethoprimsulfamethoxazole therapy for children with acute osteomyelitis. Pediatr Infect Dis J 2011;30:1019-21. doi: 10.1097/INF.0b013e31822db658
-
(2011)
Pediatr Infect Dis J
, vol.30
, pp. 1019-1021
-
-
Messina, A.F.1
Namtu, K.2
Guild, M.3
Dumois, J.A.4
Berman, D.M.5
-
15
-
-
79955780193
-
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loadingdose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections
-
doi: 10.1093/cid/cir167
-
Craft JC, Moriarty SR, Clark K, et al. A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loadingdose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections. Clin Infect Dis 2011;52(suppl 7):S520-6. doi: 10.1093/cid/cir167
-
(2011)
Clin Infect Dis
, vol.52
, Issue.7 SUPPL.
-
-
Craft, J.C.1
Moriarty, S.R.2
Clark, K.3
-
16
-
-
79955758118
-
Characterization of global patterns and the genetics of fusidic acid resistance
-
doi: 10.1093/cid/cir164
-
Farrell DJ, Castanheira M, Chopra I. Characterization of global patterns and the genetics of fusidic acid resistance. Clin Infect Dis 2011;52(suppl 7): S487-92. doi: 10.1093/cid/cir164
-
(2011)
Clin Infect Dis
, vol.52
, Issue.7 SUPPL.
-
-
Farrell, D.J.1
Castanheira, M.2
Chopra, I.3
-
17
-
-
61849122341
-
Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia
-
Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G. Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 2009;199:619-24.
-
(2009)
J Infect Dis
, vol.199
, pp. 619-624
-
-
Maor, Y.1
Hagin, M.2
Belausov, N.3
Keller, N.4
Ben-David, D.5
Rahav, G.6
-
18
-
-
0026776184
-
Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection
-
Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992;117:390-8.
-
(1992)
Ann Intern Med
, vol.117
, pp. 390-398
-
-
Markowitz, N.1
Quinn, E.L.2
Saravolatz, L.D.3
-
19
-
-
78649854733
-
Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections
-
Frei CR, Miller ML, Lewis JS 2nd, et al. Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J Am Board Fam Med 2010;23:714-9.
-
(2010)
J Am Board Fam Med
, vol.23
, pp. 714-719
-
-
Frei, C.R.1
Miller, M.L.2
Lewis II, J.S.3
-
20
-
-
77954691795
-
Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: A retrospective cohort study
-
Goldberg E, Paul M, Talker O, et al. Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study. J Antimicrob Chemother 2010;65:5.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 5
-
-
Goldberg, E.1
Paul, M.2
Talker, O.3
-
21
-
-
77957372885
-
Dissemination of an Enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus
-
doi: 10.1128/AAC.00185-10
-
Zhu W, Murray PR, Huskins WC, et al. Dissemination of an Enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54:4314-20.doi: 10.1128/AAC.00185-10
-
(2010)
Antimicrob Agents Chemother
, vol.54
, pp. 4314-4320
-
-
Zhu, W.1
Murray, P.R.2
Huskins, W.C.3
-
22
-
-
37549020378
-
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
-
Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
-
(2008)
Crit Care Med
, vol.36
, pp. 296-327
-
-
Dellinger, R.P.1
Levy, M.M.2
Carlet, J.M.3
-
23
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-83.
-
(1987)
J Chronic Dis
, vol.40
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
Mackenzie, C.R.4
-
24
-
-
0021857405
-
Validation of a prognostic score in critically ill patients undergoing transport
-
Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM. Validation of a prognostic score in critically ill patients undergoing transport. Br Med J (Clin Res Ed) 1985;291:432-4.
-
(1985)
Br Med J
, vol.291
, pp. 432-434
-
-
Bion, J.F.1
Edlin, S.A.2
Ramsay, G.3
McCabe, S.4
Ledingham, I.M.5
-
25
-
-
1642572165
-
Studies of illness in the aged. The Index of ADL: A standardized measure of biological and psychosocial function
-
Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The Index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-9.
-
(1963)
JAMA
, vol.185
, pp. 914-919
-
-
Katz, S.1
Ford, A.B.2
Moskowitz, R.W.3
Jackson, B.A.4
Jaffe, M.W.5
-
26
-
-
84872233897
-
Performance standards for antimibrobial susceptibility testing
-
Approved standard M100-S19., Wayne, PA: CLSI
-
Performance standards for antimibrobial susceptibility testing. Nineteenth informational supplement. Approved standard M100-S19. Wayne, PA: CLSI, 2009.
-
(2009)
Nineteenth Informational Supplement
-
-
-
27
-
-
77953265046
-
Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit
-
doi: 10.1001/jama.2010.757
-
Sanchez Garcia M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010;303:2260-4. doi: 10.1001/jama.2010.757
-
(2010)
JAMA
, vol.303
, pp. 2260-2264
-
-
Sanchez, G.M.1
de la Torre, M.A.2
Morales, G.3
-
28
-
-
79956086972
-
Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient: A review of the literature
-
doi: 10.1007/s10096-010-1128-3
-
van Hal SJ, Paterson DL, Gosbell IB. Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naive patient: a review of the literature. Eur J Clin Microbiol Infect Dis 2011;30:603-10. doi: 10.1007/s10096-010-1128-3
-
(2011)
Eur J Clin Microbiol Infect Dis
, vol.30
, pp. 603-610
-
-
van Hal, S.J.1
Paterson, D.L.2
Gosbell, I.B.3
-
29
-
-
79953853917
-
Does trimethoprim-sul-famethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review
-
doi: 10.1093/cid/cir067
-
Sibanda EL, Weller IV, Hakim JG, Cowan FM. Does trimethoprim-sul-famethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review. Clin Infect Dis 2011;52: 1184-94. doi: 10.1093/cid/cir067
-
(2011)
Clin Infect Dis
, vol.52
, pp. 1184-1194
-
-
Sibanda, E.L.1
Weller, I.V.2
Hakim, J.G.3
Cowan, F.M.4
-
30
-
-
80051753204
-
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus
-
doi: 10.1086/661599
-
Hayakawa K, Marchaim D, Vidaillac C, et al. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2011;32:922-4. doi: 10.1086/661599
-
(2011)
Infect Control Hosp Epidemiol
, vol.32
, pp. 922-924
-
-
Hayakawa, K.1
Marchaim, D.2
Vidaillac, C.3
-
31
-
-
77950971972
-
Hemor-rhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: A population-based study
-
doi: 10.1001/archinternmed.2010.37
-
Fischer HD, Juurlink DN, Mamdani MM, Kopp A, Laupacis A. Hemor-rhage during warfarin therapy associated with cotrimoxazole and other urinary tract anti-infective agents: a population-based study. Arch Intern Med 2010;170:617-21. doi: 10.1001/archinternmed.2010.37
-
(2010)
Arch Intern Med
, vol.170
, pp. 617-621
-
-
Fischer, H.D.1
Juurlink, D.N.2
Mamdani, M.M.3
Kopp, A.4
Laupacis, A.5
-
32
-
-
77954192913
-
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: A population-based study
-
doi: 10.1001/archinternmed.2010.142
-
Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM. Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study. Arch Intern Med 2010;170:1045-9. doi: 10.1001/archinternmed.2010.142
-
(2010)
Arch Intern Med
, vol.170
, pp. 1045-1049
-
-
Antoniou, T.1
Gomes, T.2
Juurlink, D.N.3
Loutfy, M.R.4
Glazier, R.H.5
Mamdani, M.M.6
|